Literature DB >> 5650927

7-alpha-hydroxylation of cholestanol by rat liver microsomes.

S Shefer, S Hauser, E H Mosbach.   

Abstract

In a study of the mechanism whereby 5alpha-bile acids are formed from cholestanol, the 7alpha-hydroxylation of cholestanol was investigated in rat liver preparations in vitro. It was found that in the presence of NADPH and oxygen, rat liver microsomes catalyzed the 7alpha-hydroxylation of cholestanol to the same extent as that of cholesterol. The rate of the hydroxylation was enhanced by prior treatment of the experimental rats with cholestyramine (a bile acid sequestrant) or by establishment of bile fistulas-i.e., by partial or complete removal of bile acids from the enterohepatic circulation. The 7-hydroxylation reaction was further stimulated by pretreatment of the animals with phenobarbital, a drug known to produce increased biosynthesis of hepatic endoplasmic membranes. The 7alpha-hydroxylase was inhibited by the reaction product, by sterols with 7-keto or 7beta-hydroxyl groups, and also by mono- and dihydroxy bile acids of the 5beta-series, although cholic acid or taurocholate produced no inhibition unless added in high concentrations. The results of these studies are in accord with the concept that the presence of a Delta(5)-double bond is not required for the enzymatic formation of the 7alpha-hydroxy derivative. The rate of this hydroxylation reaction in vitro appears to depend on the concentration of bile salts in the enterohepatic circulation of the experimental animals from whom the microsomes were obtained.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5650927

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  46 in total

1.  Normal antipyrine metabolism in patients with cholesterol cholelithiasis. Evidence that the disease is not due to generalized hepatic microsomal dysfunction.

Authors:  G W Hepner; E S Vesell
Journal:  Am J Dig Dis       Date:  1975-01

2.  Liver enzyme induction by the anion exchanger resin, Dower 1 X 2, in the rat.

Authors:  F E Beyhl; E Granzer
Journal:  Experientia       Date:  1977-09-15

Review 3.  Bimodal targeting of microsomal cytochrome P450s to mitochondria: implications in drug metabolism and toxicity.

Authors:  Michelle C Sangar; Seema Bansal; Narayan G Avadhani
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10       Impact factor: 4.481

4.  The control of bile acid pool size: effect of jejunal resection and phenobarbitone on bile acid metabolism in the rat.

Authors:  H Y Mok; P M Perry; R H Dowling
Journal:  Gut       Date:  1974-04       Impact factor: 23.059

5.  Regulation of bile-acid synthesis. Role of sterol carrier protein 2 in the biosynthesis of 7 alpha-hydroxycholesterol.

Authors:  H Seltman; W Diven; M Rizk; B J Noland; R Chanderbhan; T J Scallen; G Vahouny; A Sanghvi
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

6.  Effect of phenobarbital, spironolactone and pregnenolone-16 alpha-carbonitrile on bile formation in the rat.

Authors:  K von Bergmann; H P Schwarz; G Paumgartner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

7.  Age-strain interrelations in lipid metabolism of rats.

Authors:  J A Story; E Gomolinski; S K Czarnecki; S A Tepper; D Kritchevsky
Journal:  Lipids       Date:  1981-02       Impact factor: 1.880

8.  Hypolipidemic activity of 3- and 4-phenyl-piperidine-2,6-diones and selected N-substituted derivatives.

Authors:  A R Murthy; J H Maguire; R S Alphin; P A Day; I H Hall
Journal:  Lipids       Date:  1986-10       Impact factor: 1.880

9.  Age-related changes in the lipid metabolism of Fisher 344 rats.

Authors:  J A Story; S A Tepper; D Kritchevsky
Journal:  Lipids       Date:  1976-08       Impact factor: 1.880

10.  Determination of key intermediates in cholesterol and bile acid biosynthesis by stable isotope dilution mass spectrometry.

Authors:  Tadashi Yoshida; Akira Honda; Hiroshi Miyazaki; Yasushi Matsuzaki
Journal:  Anal Chem Insights       Date:  2008-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.